Join the club for FREE to access the whole archive and other member benefits.

Fay Lin

Senior Editor at GEN Biotechnology

Fay Lin is a computational biologist turned science journalist and editor. She is passionate about exploring the impact of artificial intelligence (AI) on the biotech industry, including its applications in drug discovery, precision medicine, sustainability, and beyond.

Visit website: https://www.genengnews.com/author-archive/?author-id=24485

 xiaofei-fay-lin

 xiaofei_lin

See also

Genetic Engineering & Biotechnology News (GEN)

News provider in the fields of biotechnology and genetic engineering

Details last updated 23-Jan-2025

Articles written by Fay Lin

Basecamp reveals million-species protein dataset

Basecamp reveals million-species protein dataset

Genetic Engineering & Biotechnology News (GEN) - 11-Jun-2025

Vast new dataset could supercharge AI-driven protein and drug design across biology and medicine

Boltz‑2: open‑source AI brings binding affinity modelling into every lab

Boltz‑2: open‑source AI brings binding affinity modelling into every lab

Genetic Engineering & Biotechnology News (GEN) - 06-Jun-2025

Fast, free MIT AI predicts molecular binding strength in seconds—no license needed

Evo 2: the AI model redesigning life’s genetic code

Evo 2: the AI model redesigning life’s genetic code

Genetic Engineering & Biotechnology News (GEN) - 19-Feb-2025

Arc Institute’s AI expands genetic design to complex life, advancing biotech and medicine

Roche taps Dyno Therapeutics' AI-driven capsids for neurological gene therapy

Roche taps Dyno Therapeutics' AI-driven capsids for neurological gene therapy

Genetic Engineering & Biotechnology News (GEN) - 15-Jan-2025

A partnership advancing synthetic AAV vectors to tackle gene therapy challenges